This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Kiyoshi Maruyama: Innovator in Pharmaceutical Preparations
Introduction
Kiyoshi Maruyama is an inventor based in Shizuoka, Japan, renowned for his contributions to pharmaceutical innovations. With a focus on nasal drop preparations, Maruyama's inventive spirit is reflected in his singular patent, demonstrating his commitment to advancements in medical science.
Latest Patents
Maruyama holds a patent for "Pralmorelin-containing nasal drop preparations." This innovative preparation is designed for intranasal administration and comprises D-alanyl-3-(naphthalen-2-yl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide (pralmorelin) and/or its acid addition salt as an active ingredient. The formulation enhances in vivo absorption of pralmorelin, providing effective results even with smaller doses. Additionally, it allows for a greater dissolution capacity of pralmorelin, facilitating easier pharmaceutical formulation while also demonstrating high stability over time.
Career Highlights
Currently, Kiyoshi Maruyama is associated with Kaken Pharmaceutical Company, Ltd., where he works on advancing pharmaceutical technologies. His research aims to improve drug delivery systems, particularly in relation to nasal applications, showcasing his dedication to enhancing therapeutic outcomes.
Collaborations
Throughout his career, Maruyama has collaborated with notable colleagues, including Akiko Ochiai and Yasutomi Kato. These collaborations have played a significant role in furthering his research and development efforts, contributing to the innovation of effective pharmaceutical solutions.
Conclusion
Kiyoshi Maruyama stands out as an impactful inventor in the pharmaceutical industry, with his patented innovations opening new avenues for drug absorption and formulation. His work not only illustrates the potential of nasal administration methods but also highlights the collaborative spirit essential for scientific progress in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
